The goals of this Neurogenetics Center are to elucidate the molecular etiology and to ameliorate the course of hereditary tumors of the nervous system, in particular in neurofibromatosis type 2 (NF2) and tuberous sclerosis (TSC) This research will provide insight into the etiology of spontaneous neural tumors and mechanisms of growth regulation in the developing nervous system. The focus of the proposed studies is on understanding the genetic basis of functional changes in merlin (NF2), hamartin (TSC1) and tuberin (TSC2) and their role in formation and progression of meningiomas and other brain tumors. Elucidation of the cellular function of these proteins will be facilitated through identification and characterization of interacting proteins. Further, transgenic mouse models of these diseases will be used to understand physiologic changes associated with loss of these tumor suppressor genes and to provide a platform for therapeutic strategies. Project 10 (Gusella)-Molecular genetics of meningioma and NF-related disorders: elucidate cellular functions of merlin in growth and adhesion; determine the role of this and other genes in the ontogeny and progression of meningiomas; and identify genes involved in related, hereditary neural tumor syndromes; Project 11 (Ramesh, Ito)-Characterization of TSC proteins hamartin and tuberin: determine whether cortical lesions in TSC patients have loss of heterozygosity at the cellular level; and characterize the role of tuberin in control of cell cycle via elucidation of interacting proteins in mammalian cells and Drosophila; Project 12 (Kwiatkowski)-Murine models of TSC1: mechanisms and therapies: generate and characterize knock-out and conditional transgenic mice for TSC1 in the homozygous and heterozygous states and in different genetic backgrounds; characterize the phenotypic consequences of missense mutations in TSC1; and attempt to arrest cell growth in lesions using vectors. Project 13 (Breakefield, Brown)-Gene therapy for hereditary tumors in experimental models of TSC: evaluate gene delivery in mouse models of liver hemangioma, cortical harmartomas and renal cell carcinoma (TSC2+/-); generate brain lesions in TSC1 conditional knock-out animals by injection of Cre-bearing vectors; and test gene therapy models in vivo with herpes hybrid amplicon vectors and endothelial cell vehicles bearing genes for anti-angiogenic and apoptotic factors. These projects will be supported by Cores for Clinical Services (Sims, MacCollin) and Neuropathology and Tumor Banking (Louis and Stemmer-Rachamimov). Collectively these studies provide a concerted effort towards understanding the neurologic functions of NF2 and TSC genes and treating disease manifestations associated with these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS024279-18
Application #
6799624
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Tagle, Danilo A
Project Start
1987-01-23
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
18
Fiscal Year
2004
Total Cost
$1,599,418
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Jordan, Justin T; Smith, Miriam J; Walker, James A et al. (2018) Pain correlates with germline mutation in schwannomatosis. Medicine (Baltimore) 97:e9717
Prabhakar, Shilpa; Zhang, Xuan; Goto, June et al. (2015) Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. Neurobiol Dis 82:22-31
Geffrey, Alexandra L; Shinnick, Julianna E; Staley, Brigid A et al. (2014) Lymphedema in tuberous sclerosis complex. Am J Med Genet A 164A:1438-42
Boronat, Susana; Shaaya, Elias A; Auladell, Maria et al. (2014) Intracranial arteriopathy in tuberous sclerosis complex. J Child Neurol 29:912-9
Di Nardo, Alessia; Wertz, Mary H; Kwiatkowski, Erica et al. (2014) Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1. Hum Mol Genet 23:3865-74
Shaaya, Elias A; Hirshberg, Jacqueline S; Rabe, Olivia T et al. (2013) Cardiac fat-containing lesions are common in tuberous sclerosis complex. Am J Med Genet A 161A:1662-5
Boronat, Susana; Van Eeghen, Agnies M; Shinnick, Julianna E et al. (2013) Stressor-related disorders in tuberous sclerosis. Ann Clin Psychiatry 25:243-9
van Eeghen, Agnies M; TerĂ¡n, Laura Ortiz; Johnson, Jason et al. (2013) The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines. Neuroradiology 55:1007-1014
Prabhakar, Shilpa; Taherian, Mehran; Gianni, Davide et al. (2013) Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1. Hum Gene Ther 24:152-62
Hsieh, David T; Jennesson, Melanie M; Thiele, Elizabeth A (2013) Epileptic spasms in tuberous sclerosis complex. Epilepsy Res 106:200-10

Showing the most recent 10 out of 261 publications